Takeda Slams FDA Approval Of Rival's Gout Drug At DC Circ.
Takeda Pharmaceuticals USA Inc. on Friday blasted the U.S. Food and Drug Administration for violating patent protections when it approved West-Ward Pharmaceuticals Corp.'s competing gout drug, Mitigare, urging the D.C. Circuit to...To view the full article, register now.
Already a subscriber? Click here to view full article